Cerebral palsy is a group of disorders that affect movement and posture as a result of non-progressive damage to the developing brain. It has an incidence of 3 per 1000 children and is commonly caused by cerebral malformations in developed countries and perinatal asphyxia in developing countries. Clinically, it presents with delayed development, abnormal muscle tone and posture, seizures, and intellectual disability. Diagnosis involves assessing developmental history and physical signs of spasticity, contractures, and hyperreflexia. Management is multi-disciplinary and includes medications, physiotherapy, orthotics, and occasionally surgery. Prognosis depends on severity of deficits and early intervention, with earlier ability to sit associated with later ability to
This slide was prepared for teaching purpose to medical students. It contain information from different books and medical journals. please inform if any of the information given need to be changed.
A group of motor impairment syndromes resulting from disorders of early brain development and often associated with epilepsy and abnormalities of speech, vision and intellect
This slide was prepared for teaching purpose to medical students. It contain information from different books and medical journals. please inform if any of the information given need to be changed.
A group of motor impairment syndromes resulting from disorders of early brain development and often associated with epilepsy and abnormalities of speech, vision and intellect
Cerebral palsy (CP) is a disorder that affects muscle tone, movement, and motor skills (the ability to move in a coordinated and purposeful way). CP usually is caused by brain damage that happens before or during a baby's birth, or during the first 3 to 5 years of a child's life.
Diagnosis and Management of Special Populations 2010Dominick Maino
Diagnosis and Management of Special Populations presents the latest in the assessment and treatment of those with physical, cognitive, and behavioral abnormalities. Up to date information concerning the etiology, prevalence/incidence and physical/cognitive findings of individuals with developmental/acauired disabilities (Cerebral palsy, Down syndrome, Fragile X syndrome, autism, acquired/traumatic brain injury) will be discussed. New diagnostic and treatment techniques are reviewed. The eye care practitioner will be able to confidently provide eye and vision care for those with disability at the end of this presentation.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
1. Cerebral Palsy
in Children
Definition, Epidemiology, Etiology, Clinical Features,
Diagnosis, Assessment, Management, Prognosis and Prevention
Prof. Imran Iqbal
Fellowship in Pediatric Neurology (Australia)
Prof of Paediatrics (2003-2018)
Prof of Pediatrics Emeritus, CHICH
Prof of Pediatrics, CIMS
Multan, Pakistan
2. (God Almighty speaking to Prophet Muhammad (PBUH)
Say, “It is He who created and nurtured you;
and given you the hearing, the vision, and the thinking.
But rarely do you pay gratitude.”
The Holy Quran; surah Al-Mulk 67:23
In the name of Our Creator Allah, the most Gracious, the most Merciful
7. CNS – Abnormal Symptoms
• Convulsions
• Altered Consciousness
• Delayed development
• Intellectual handicap
• Speech problem
• Motor weakness / Walking problem
• Sensory changes
• Headache
• Unable to see / listen
8. History – Ask about Symptoms
• Neurological Symptoms –
• Onset
• Frequency
• Severity
• Progression
• Birth history
• Development history
• Family history
11. Examination of CNS in Children
• OBSERVE – observe the child
• General Physical Examination
• Developmental Examination
• NEUROLOGICAL EXAMINATION –
• Higher Mental Functions
• Cranial Nerves
• Motor System
• Sensory system
• Skull and Spine
• SOMI
14. Areas of Development
Posture and locomotion
Vision and manipulation
Hearing and speech
Personal and social
15. Areas of Development
Posture and locomotion
Vision and manipulation
Hearing and speech
Personal and social
16. Milestones of Development
Posture and locomotion
3 months – Head control
6 months – Roll over
9 months -– sit without support
12 months – stand / walk held
17. Milestones of Development
Vision and manipulation (eye – hand coordination)
3 mo – Eyes fix and follow
6 mo – Hand approach to hold
9 mo -– Finger grasp
12 mo – Release object in examiner’s hand
22. Higher Mental Functions
• Conscious Level (Glasgow Coma Scale)
• Recognition and Response
• Behavior and activity
• Speech
• Memory
23. Cranial Nerves
• Visual focusing and following
• Light reflex
• Facial Movements
• Response to sound
• Sucking and Swallowing
• Palate movement and Gag reflex
24. Motor System
• Presence of spontaneous voluntary movements in
infant
• Size and Nutrition of muscles
• Tone
• Power
• Deep Tendon Reflexes
• Planter Reflex
• Gait
• Co-ordination
• Involuntary Movements
34. Friday, October 29, 2021 CEREBRAL PALSY by DR. NAVEED ANJUM 34
Cerebral Palsy – Clinical Description
Damage to
Developing Brain
Disorder of
Movement
and Posture
Non-
progressive
35. Cerebral Palsy
Definition
• Cerebral Palsy is a group of disorders of movement and
posture causing activity limitation due to non-progressive
disturbances in the developing fetal or infant brain.
• Cerebral Palsy affects mainly movement produced by
skeletal muscles and posture of the body
• Cerebral Palsy results in delayed development
• Cerebral Palsy causes activity limitation
• Cerebral Palsy is produced by damage to developing fetal or
infant brain
36. Cerebral Palsy
Epidemiology
• Incidence: 3 / 1000 children
• Predisposing Factors / Etiology
• Most common cause in developed countries is a Cerebral
malformation
• Most common cause in developing countries is Perinatal
Asphyxia
37. Cerebral Palsy
Etiology
Pre – natal
Cerebral
malformations
Chorio-
amnionitis
TORCH
infections
Peri – natal
Perinatal
asphyxia
Preterm
VLBW
Post –natal
Meningitis
Intra-cranial
hemorrhage
Cerebrovascular
accidents
Kernicterus
43. Case Scenario
Clinical History
• A 3 year old child presents with inability to walk.
• Development History
• Child started sitting at 18 months of age. He has not started
walking
• He is able to move forward in a sitting position with help of his
arms
• He recognizes his parents and has started speaking few words
• Birth History
• He was born at a clinic after a term pregnancy
• He had delayed cry after birth, and remained in hospital for few
days
• There is history of seizures in first week of life, and later during
febrile illnesses
44. Case Scenario
Clinical Examination
• On examination, his OFC is 46 cm
• Internal squint is seen in eyes
• There is drooling of saliva from the mouth
• Motor system examination shows hypertonia and hyper-reflexia
• He stands with support on his toes with legs crossed
• He can take a few steps sideways holding on to furniture
• What is your most likely diagnosis ?
• Cerebral Palsy (spastic type)
45. Cerebral Palsy
Clinical Features - Symptoms
• Delayed development
Posture and locomotion
Vision and manipulation
Hearing and speech
Personal and social
• Stiffness of muscles / neck extended / arching of back
• Seizures
• Unable to take solid foods
• Constipation
46. Cerebral Palsy
Clinical Features - Signs
• Microcephaly
• Drooling of saliva, difficulty in swallowing
• Neck extended / arching of back
• Fisting of hands
• Scissoring of legs
• Spasticity of muscles – hypertonia, hyper-reflexia
• Reduced range of movement of skeletal muscles
• Persistence of primitive reflexes
• Abnormal position and posture of the body
• Secondary musculoskeletal problems
47. Cerebral Palsy
Diagnosis
• History –
• Patient complaints – Delayed Development
• Birth History – fetal distress, delayed cry, meningitis in infancy
• Family History – No H/O delayed development in other sibs
• Physical signs –
• Microcephaly
• Drooling of saliva, difficulty in swallowing
• Fisting of hands
• Scissoring of legs
• Spasticity of muscles – hypertonia, hyper-reflexia
49. Cerebral Palsy
Patient Evaluation
• Birth History – Perinatal hypoxia
• Development history – delay in one or more areas
• Developmental disabilities of child
• Posture, movements and mobility
• Vision
• Hearing and speech
• Behavior
• Associated problems
56. Cerebral Palsy
Physiotherapy and Rehabilitation
Physiotherapy
• Positioning of body – to relax the muscles
• Passive Exercises – range of motion
• Active movements – teaching daily activities
Occupational therapy
• Hand function techniques, Feeding techniques
Speech therapy
• Language and Communication skills
Rehabilitation therapy
• Splints / Orthotic supports, Walking aids
57. Cerebral Palsy
Surgery
• Usually performed by 10 years of age
• Relieve the contractures –
= Tendo-achilles
= Adductors
• Strengthen the weak movements – tendon transfer
58. Cerebral Palsy
Prognosis
• Severity – of neurological deficits
• Management – Early diagnosis and Effective Management
• Progress of child – if the child is able to sit by 2 years of age,
he is expected to walk by 5 years of age
59. Cerebral Palsy
Prevention
Efficient medical care during Pregnancy
Prevention of Birth asphyxia during birth of baby
Early management of Neonatal disorders
Effective management of Neurological diseases in infancy
60. UN Convention on the Rights of the Child
1989
“A disabled child has the right to enjoy
a full and decent life,
in conditions which
ensure dignity,
promote self-reliance
and
facilitate the child’s active participation
in the community.”